Treatment options of AIDS-related lymphoma.
Recently, the median survival of patients with AIDS-related lymphoma has changed significantly. This effect is mainly because of changes in the use of antiviral (highly active antiretroviral therapy; HAART) or chemotherapy regimens. Several novel treatment options have been explored in patients with lymphoma. It is hoped that innovative strategies will lead to a survival benefit in these patients. In this review, we present an update of current strategies for the treatment of AIDS-related lymphoma.
Schmidt-Wolf
Ingo G H
IG
Medizinische Universitätsklinik und Poliklinik I, Sigmund-Freud-Str 25, 53105 Bonn, Germany. picasso@uni-bonn.de
Rockstroh
Jürgen K
JK
Schlegel
Uwe
U
Pels
Hendrik
H
Mey
Ulrich
U
Strehl
John
J
Weiss
Rudolf
R
Huhn
Dieter
D
D000970:Antineoplastic Agents / Q000008:administration & dosage / Q000627:therapeutic use*; D023241:Antiretroviral Therapy, Highly Active; D015658:HIV Infections / Q000188:drug therapy; D006801:Humans; D006918:Hydroxyurea / Q000627:therapeutic use; D007167:Immunotherapy; D016483:Lymphoma, AIDS-Related / Q000150:complications / Q000188:drug therapy* / Q000473:pathology; D033581:Stem Cell Transplantation
D000970:Antineoplastic Agents; D006918:Hydroxyurea